Clinical manifestations are complex and often involve multiple systems. Early identification and standardized clinical care are essential for improving prognosis. Diagnosis of the disease requires a combination of clinical manifestations, imaging checks, laboratory tests and pathological activation.
The platform can help align domestic and foreign experts and teams to provide accurate diagnostics and treatment plans. Treatment for management of short-term complexity requires individualized development of treatment plans, typically including drug therapy, rehabilitation interventions, regular follow-up, and other multidimensional management. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many autoimmune and rheumatic immune diseases that have previously been difficult to treat have been significantly improved.
Therapeutic efficacy and adverse reactions need to be closely monitored and timely adjusted according to changes in the course of treatment. Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of short-term syndrome. The platform serves the China International Medical Service System, a team of internationally authoritative experts in the field of autoimmune and rheumatic immunity, to provide the following services to patients: Remote pre-diagnosis: The team of experts reviews the patient's medical history, clarifies the direction of diagnosis and offers medical advice: 1.
2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.